Clifford Chance LLP’s broad offering encompasses an array of advisory, disputes and transactional work. Stephen Reese helms the ‘excellent and engaging’ practice with considerable experience advising clients on both contentious and non-contentious aspects as well as being particularly active in the healthcare and life sciences sectors, while Vanessa Marsland is well-versed in handling brand-related patent work. Don McCombie joined in June 2022 from Ashurst, bolstering the practice with expertise in handling IP disputes and transactions.
Testimonials
Collated independently by Legal 500 research team.
‘An excellent and engaging team of great individuals who deliver a highly friendly and professional service.’
‘Professionalism and reliability truly sum up our incredible experience with Clifford Chance.'
- 'Whoever we need to engage with, the reassurance, peace of mind and level of client service we receive is exceptional. The various areas of expertise within Clifford Chance always work well together to support us as a client and understand our needs, perspective and queries really well.’
- 'These individuals are proactive in bringing matters to our attention that we may have otherwise been unaware of. This ability to be so solution focused helps us to operate successfully and mitigate and manage risks.'
Key clients
- Cyprus Government and the Foundation for the Protection of the Traditional Cheese of Cyprus Named Halloumi
- Avilease
- Permira
- Goldman Sachs
- Skoda
- ORBIS
- Melrose
- Invictus Games Foundation
- Ultrahuman Healthcare Private Limited
- LZ Labs
- Mondelez
- BlackRock
- Pfizer
- Informa
- UK Government
- Kuwait Food Company
- Huawei Technologies
- arbdn
- WSH Services Holding Limited
- Infracapital Greenfield Partners II
- Fujitsu Services
- Baker Hughes
- Public Investment Fund
Work highlights
- Advised Vectura Group plc on the public takeover by Philip Morris SA of Vectura Group plc. The firm's IP group were involved in the workaround reviewing Vectura's complex set of patent assets and patent licensing arrangements concerning its products.
- Retained to advise a software development company on the enforcement of their patents filed with respect to digital encryption technologies.
- Advised a pharmaceutical client on the patent aspects of innovative artificial technologies being used in the field of drug discovery and drug development activities.
Practice head
The lawyer(s) leading their teams.
Stephen Reese